A detailed history of Conestoga Capital Advisors, LLC transactions in Iradimed Corp stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 27,555 shares of IRMD stock, worth $1.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
27,555
Previous 27,555 -0.0%
Holding current value
$1.47 Million
Previous $1.21 Million 14.46%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$40.36 - $44.7 $4,036 - $4,470
-100 Reduced 0.36%
27,555 $1.21 Million
Q1 2024

Apr 26, 2024

BUY
$41.17 - $47.29 $488,893 - $561,568
11,875 Added 75.25%
27,655 $1.22 Million
Q4 2023

Jan 26, 2024

BUY
$37.31 - $47.47 $588,751 - $749,076
15,780 New
15,780 $749,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $668M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Conestoga Capital Advisors, LLC Portfolio

Follow Conestoga Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.